Minerva Neurosciences (NERV) Enterprise Value Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Minerva Neurosciences | 215.11 Mn | 215.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.55% |
| Dec 31, 2025 | -26.48% |
| Sep 30, 2025 | 17.60% |
| Jun 30, 2025 | 13.86% |
| Mar 31, 2025 | 10.41% |
| Dec 31, 2024 | 14.09% |
| Sep 30, 2024 | 6.87% |
| Jun 30, 2024 | -2.08% |
| Mar 31, 2024 | -2.60% |
| Dec 31, 2023 | 4.01% |
| Sep 30, 2023 | 11.67% |
| Jun 30, 2023 | 5.48% |
| Mar 31, 2023 | 4.42% |
| Dec 31, 2022 | 23.01% |
| Sep 30, 2022 | 16.06% |
| Jun 30, 2022 | 8.46% |
| Mar 31, 2022 | -27.18% |
| Dec 31, 2021 | 8.20% |
| Sep 30, 2021 | 6.49% |
| Jun 30, 2021 | 5.20% |
| Mar 31, 2021 | -12.44% |
| Dec 31, 2020 | 4.59% |
| Sep 30, 2020 | 2.75% |
| Jun 30, 2020 | 1.78% |
| Mar 31, 2020 | 10.41% |
| Dec 31, 2019 | -19.85% |
| Sep 30, 2019 | -9.96% |
| Jun 30, 2019 | -125.43% |
| Mar 31, 2019 | -70.34% |
| Dec 31, 2018 | -94.29% |
| Sep 30, 2018 | -139.88% |
| Jun 30, 2018 | -115.44% |